back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-09-11 11:59 Tx date 2024-09-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,044
+400 vol $2.61 each |
224,865 | |
| Filed 2024-09-11 11:57 Tx date 2024-09-04 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,095
+1,500 vol $2.73 each |
224,465 | |
| Filed 2024-06-17 16:09 Tx date 2024-06-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,926
+1,100 vol $2.66 each |
222,965 | |
| Filed 2024-06-12 12:08 Tx date 2024-06-11 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,248
+800 vol $2.81 each |
221,865 | |
| Filed 2024-06-09 21:38 Tx date 2024-06-07 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,730
+1,000 vol $2.73 each |
221,065 | |
| Filed 2024-05-22 23:09 Tx date 2024-05-13 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$178,200
+45,000 vol $3.96 each |
170,000 | |
| Filed 2024-05-22 23:05 Tx date 2024-05-10 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,920
+640 vol $3.00 each |
220,065 | |
| Filed 2023-08-20 10:41 Tx date 2023-08-18 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$19,999
+2,857 vol $7.00 each |
219,425 | |
| Filed 2022-12-12 20:22 Tx date 2022-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$57,750
+15,000 vol $3.85 each |
125,000 | |
| Filed 2022-12-12 20:20 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
134,508 | |
| Filed 2021-11-19 15:17 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
||
| Filed 2022-06-09 01:45 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,041
+900 vol $1.16 each |
216,568 | |
| Filed 2022-06-09 01:44 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$579.10
+500 vol $1.16 each |
215,668 | |
| Filed 2022-06-09 01:44 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,991
+18,000 vol $1.17 each |
215,168 | |
| Filed 2022-06-09 01:43 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$119.48
+100 vol $1.19 each |
197,168 | |
| Filed 2022-06-09 01:42 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,198
+1,000 vol $1.20 each |
197,068 | |
| Filed 2022-06-09 01:42 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,991
+5,000 vol $1.20 each |
196,068 | |
| Filed 2022-06-09 01:41 Tx date 2022-06-08 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$67,872
+56,560 vol $1.20 each |
191,068 | |
| Filed 2021-12-13 12:56 Tx date 2021-12-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$20,200
+10,000 vol $2.02 each |
110,000 | |
| Filed 2021-11-19 15:17 Tx date 2021-11-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$39,801
+22,014 vol $1.81 each |
134,508 | |
| Filed 2021-10-26 19:07 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$24,396
+3,050 vol $8.00 each |
68,050 | |
| Filed 2021-10-26 19:05 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants
15 - Acquisition or disposition under a prospectus
|
+1,525 vol |
1,525 | |
| Filed 2021-10-26 18:58 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-09-24 16:58 Tx date 2021-09-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,536
+2,100 vol $2.16 each |
109,444 | |
| Filed 2021-09-24 16:58 Tx date 2021-09-14 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$91,463
+42,344 vol $2.16 each |
107,344 | |
| Filed 2021-03-12 12:54 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Warrants Founder Warrants
00 - Opening Balance-Initial SEDI Report
|
10,000 | ||
| Filed 2021-03-12 12:36 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$240,000
+30,000 vol $8.00 each |
100,000 | |
| Filed 2021-03-12 12:30 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
70,000 | ||
| Filed 2021-03-12 12:29 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Wilmink, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
65,000 |